We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
-5.84%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$5.99B
AUM Growth
-$571M
Cap. Flow
-$107M
Cap. Flow %
-1.78%
Top 10 Hldgs %
12.64%
Holding
363
New
17
Increased
100
Reduced
214
Closed
10
Avg Time Held
7.5 quarters
Top 10 Avg Time Held
5.1 quarters
Top 20 Avg Time Held
5.8 quarters

Top Buys

Rank Stock Value
1
ACH icon
Accendra Health
ACH
+$32.5M
2
CHE icon
Chemed
CHE
+$26.3M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$21.6M
4
OII icon
Oceaneering
OII
+$14.8M
5
EV icon
Eaton Vance Corp.
EV
+$14.2M

Top Sells

Rank Stock Value
1
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
+$39.6M
2
THOR icon
THORATEC CORPORATION
THOR
+$27.6M
3
DTV
DIRECTV COM STK (DE)
DTV
+$26M
4
IPCM
IPC HEALTHCARE INC COM DTD
IPCM
+$24M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$19.1M

Sector Composition

Rank Sector Weight
1 Financials 18.71%
2 Healthcare 16.61%
3 Technology 15.56%
4 Industrials 12.77%
5 Consumer Discretionary 11.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.05T
$95.9M 1.6%
3,478,152
+8,828
+0.3% +$259K
2013 Q2
9 quarters
NKE icon
2
Nike
NKE
$51.8B
$95.2M 1.59%
1,548,300
-14,718
-0.9% -$833K
2013 Q2
9 quarters
COST icon
3
Costco
COST
$429B
$74.6M 1.25%
516,051
+173
+0% +$24.7K
2013 Q2
9 quarters
MSFT icon
4
Microsoft
MSFT
$4T
$74.2M 1.24%
1,676,548
-6,766
-0.4% -$304K
2013 Q2
9 quarters
ATR icon
5
AptarGroup
ATR
$7.62B
$72.9M 1.22%
1,104,703
-19,449
-2% -$1.29M
2013 Q2
9 quarters
ACN icon
6
Accenture
ACN
$132B
$72.5M 1.21%
737,486
-54,829
-7% -$5.44M
2013 Q2
9 quarters
JNJ icon
7
Johnson & Johnson
JNJ
$606B
$71.1M 1.19%
762,116
-463
-0.1% -$44.8K
2013 Q2
9 quarters
TROW icon
8
T. Rowe Price
TROW
$21.3B
$68.3M 1.14%
983,045
-15,255
-2% -$1.13M
2013 Q2
9 quarters
BCR
9
DELISTED
CR Bard Inc.
BCR
$66.2M 1.11%
355,548
-18,189
-5% -$3.44M
2013 Q2
9 quarters
GWW icon
10
W.W. Grainger
GWW
$61.6B
$65.9M 1.1%
306,386
+2,473
+0.8% +$555K
2013 Q2
9 quarters
BDX icon
11
Becton Dickinson
BDX
$50.8B
$63.9M 1.07%
493,542
-1,856
-0.4% -$259K
2013 Q2
9 quarters
CB icon
12
DELISTED
CHUBB CORPORATION
CB
$63M 1.05%
513,920
-152,633
-23% -$18.7M
2013 Q2
9 quarters
CINF icon
13
Cincinnati Financial
CINF
$25.2B
$61.4M 1.03%
1,142,135
+26,237
+2% +$1.41M
2013 Q2
9 quarters
MMM icon
14
3M
MMM
$84.5B
$58M 0.97%
489,613
+7,074
+1% +$870K
2013 Q2
9 quarters
BOH icon
15
Bank of Hawaii
BOH
$2.59B
$56.6M 0.94%
890,902
-94,956
-10% -$6.16M
2013 Q2
9 quarters
OMC icon
16
Omnicom Group
OMC
$21.3B
$56.4M 0.94%
855,521
+3,940
+0.5% +$276K
2013 Q2
9 quarters
JPM icon
17
JPMorgan Chase
JPM
$884B
$55.9M 0.93%
917,070
-9,483
-1% -$621K
2013 Q2
9 quarters
ESRX
18
DELISTED
Express Scripts Holding Company
ESRX
$53.9M 0.9%
665,943
+10,950
+2% +$954K
2013 Q2
9 quarters
PEP icon
19
PepsiCo
PEP
$174B
$53.5M 0.89%
567,137
-10,162
-2% -$967K
2013 Q2
9 quarters
ITW icon
20
Illinois Tool Works
ITW
$76.1B
$52.5M 0.88%
637,535
-20,889
-3% -$1.83M
2013 Q2
9 quarters
ADP icon
21
Automatic Data Processing
ADP
$110B
$52.3M 0.87%
650,574
+934
+0.1% +$74.8K
2013 Q2
9 quarters
ROST icon
22
Ross Stores
ROST
$72.3B
$52M 0.87%
1,073,458
-2,070
-0.2% -$106K
2013 Q2
9 quarters
PG icon
23
Procter & Gamble
PG
$359B
$50.6M 0.85%
703,288
-5,176
-0.7% -$388K
2013 Q2
9 quarters
XOM icon
24
ExxonMobil
XOM
$721B
$48.9M 0.82%
658,219
-9,577
-1% -$738K
2013 Q2
9 quarters
PNC icon
25
PNC Financial Services
PNC
$85.6B
$47.9M 0.8%
537,143
-1,270
-0.2% -$119K
2013 Q2
9 quarters
1
2 3 4 5

Similar funds

MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
GLA
Great Lakes Advisors Chicago, Illinois $13.1B AUM 34.09% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $13.1B AUM 19.56% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.3B AUM 29.38% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

Boston Trust Walden's Q3 2015 Portfolio in Review

As of Q3 2015, Boston Trust Walden held 363 positions worth $5.99B, down 8.7% from $6.56B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Boston Trust Walden's Q3 2015 filing shows 17 new, 100 increased, 214 reduced and 10 closed positions. Its largest new stake was Accendra Health: 954,271 shares worth $30.5M. The largest sale was BIO-REFERENCE LABS INC-NEW-, an estimated $39.6M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q3 2015 buy was Accendra Health: 954,271 shares worth $30.5M.
  • Boston Trust Walden added most to Oceaneering in Q3 2015, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $19.1M.
  • Boston Trust Walden fully exited BIO-REFERENCE LABS INC-NEW- in Q3 2015, selling an estimated $39.6M.
  • Boston Trust Walden's ten largest holdings make up 13% of its $5.99B portfolio in Q3 2015.
  • Boston Trust Walden opened 17 new positions and closed 10 in Q3 2015.
  • Boston Trust Walden's portfolio value fell 8.7% quarter-over-quarter to $5.99B.

Based on Boston Trust Walden's 13F filing for Q3 2015, filed 29 Oct 2015.